These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9717343)

  • 21. Reexamination of the characteristics of the deficit schizophrenia patients.
    Tiryaki A; Yazici MK; Anil AE; Kabakçi E; Karaağaoğlu E; Göğüş A
    Eur Arch Psychiatry Clin Neurosci; 2003 Oct; 253(5):221-7. PubMed ID: 14504990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Context-processing deficits in schizophrenia: diagnostic specificity, 4-week course, and relationships to clinical symptoms.
    Barch DM; Carter CS; MacDonald AW; Braver TS; Cohen JD
    J Abnorm Psychol; 2003 Feb; 112(1):132-43. PubMed ID: 12653421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The negative symptoms of schizophrenia: category or continuum?
    Kaiser S; Heekeren K; Simon JJ
    Psychopathology; 2011; 44(6):345-53. PubMed ID: 21847001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity.
    Nuechterlein KH; Green MF; Kern RS; Baade LE; Barch DM; Cohen JD; Essock S; Fenton WS; Frese FJ; Gold JM; Goldberg T; Heaton RK; Keefe RS; Kraemer H; Mesholam-Gately R; Seidman LJ; Stover E; Weinberger DR; Young AS; Zalcman S; Marder SR
    Am J Psychiatry; 2008 Feb; 165(2):203-13. PubMed ID: 18172019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Indicators of prostaglandin synthase activity in thrombocytes of patients with schizophrenia with positive and negative disorders].
    Geling NG; Klimenko TV; Milekhin GN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(4):99-101. PubMed ID: 1650110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The study of social cognition with neuroimaging methods as a means to explore future directions of deficit evaluation in schizophrenia?
    Brunet-Gouet E; Achim AM; Vistoli D; Passerieux C; Hardy-Baylé MC; Jackson PL
    Psychiatry Res; 2011 Nov; 190(1):23-31. PubMed ID: 21185085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The psychiatric symptomatology of deficit schizophrenia: a meta-analysis.
    Cohen AS; Brown LA; Minor KS
    Schizophr Res; 2010 May; 118(1-3):122-7. PubMed ID: 19887305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurocognitive impairment in the deficit subtype of schizophrenia.
    Fervaha G; Agid O; Foussias G; Siddiqui I; Takeuchi H; Remington G
    Eur Arch Psychiatry Clin Neurosci; 2016 Aug; 266(5):397-407. PubMed ID: 26260899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The deficit syndrome in schizophrenia: implications for the treatment of negative symptoms.
    Arango C; Buchanan RW; Kirkpatrick B; Carpenter WT
    Eur Psychiatry; 2004 Feb; 19(1):21-6. PubMed ID: 14969777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation of the German version of the brief assessment of cognition in Schizophrenia (BACS) - preliminary results.
    Sachs G; Winklbaur B; Jagsch R; Keefe RS
    Eur Psychiatry; 2011 Mar; 26(2):74-7. PubMed ID: 20427153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The assessment of neuropsychological functioning in schizophrenia.
    Reichenberg A
    Dialogues Clin Neurosci; 2010; 12(3):383-92. PubMed ID: 20954432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spanish validation of the Brief Assessment in Cognition in Schizophrenia (BACS) in patients with schizophrenia and healthy controls.
    Segarra N; Bernardo M; Gutierrez F; Justicia A; Fernadez-Egea E; Allas M; Safont G; Contreras F; Gascon J; Soler-Insa PA; Menchon JM; Junque C; Keefe RS
    Eur Psychiatry; 2011 Mar; 26(2):69-73. PubMed ID: 20435446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuropsychological performance of psychotic patients in community care: results from the UK700 study.
    Gilvarry CM; Barber JA; van Os J; Murray RM;
    Acta Psychiatr Scand Suppl; 2001; (408):81-91. PubMed ID: 11730077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Schizophrenia, IX: Cognition in schizophrenia--the MATRICS initiative.
    Marder SR; Fenton W; Youens K
    Am J Psychiatry; 2004 Jan; 161(1):25. PubMed ID: 14702244
    [No Abstract]   [Full Text] [Related]  

  • 35. Psychiatric symptom versus neurocognitive correlates of diminished expressivity in schizophrenia and mood disorders.
    Cohen AS; Kim Y; Najolia GM
    Schizophr Res; 2013 May; 146(1-3):249-53. PubMed ID: 23481582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Executive functioning in schizophrenia and the relationship with symptom profile and chronicity.
    Greenwood KE; Morris R; Sigmundsson T; Landau S; Wykes T
    J Int Neuropsychol Soc; 2008 Sep; 14(5):782-92. PubMed ID: 18764973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurocognitive impairments in schizophrenia: a piece of the epigenetic puzzle.
    Asarnow RF
    Eur Child Adolesc Psychiatry; 1999; 8 Suppl 1():I5-8. PubMed ID: 10546977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Remarks regarding disorders of cognitive functions in the pathomechanism of schizophrenia].
    Czerwiński A
    Psychiatr Pol; 1980; 14(1):59-62. PubMed ID: 7367520
    [No Abstract]   [Full Text] [Related]  

  • 39. [Deficit of the theory-of-mind in schizophrenia: clinical concept and review of experimental arguments].
    Sarfati Y
    Can J Psychiatry; 2000 May; 45(4):363-8. PubMed ID: 10813070
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary and persistent negative symptoms: Concepts, assessments and neurobiological bases.
    Mucci A; Merlotti E; Üçok A; Aleman A; Galderisi S
    Schizophr Res; 2017 Aug; 186():19-28. PubMed ID: 27242069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.